Skip to main content
. Author manuscript; available in PMC: 2012 Jul 26.
Published in final edited form as: Nature. 2012 Jan 11;481(7382):506–510. doi: 10.1038/nature10738

Figure 3. Comparison of mutational classes between primary tumors and relapse samples.

Figure 3

a) Fraction of the primary tumor and relapse-specific mutations in each of the transition and transversion categories. b) Transversion frequencies of the primary tumor and relapse-specific mutations from 8 AML tumor and relapse pairs. 456 relapse-specific mutations and 3590 primary tumor mutations from 8 cases were used for assessing statistical significance using proportion tests.